Key facts
- This page summarizes George M. Milne Jr.'s Form 4 filing for Amylyx Pharmaceuticals, Inc. (AMLX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Jan 2026, 16:08.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Gift
Additional SEC filing notes
Footnote F1
Represents a bona fide gift for no consideration.